Bioinformatics analysis of CTL1 and CTL2 mRNA expression was performed on normal and PAAD patient samples from the Cancer Genome Atlas (TCGA) database (UALCAN website; Figure S1). The gene discussed is SLC44A1; the disease is pancreatic adenocarcinoma.